Literature DB >> 19353242

Relationship between factor XII deficiency and thrombosis: the debate is still open?

Gianfranco Lessiani, Angela Falco, Elvira Nicolucci, Giancarlo Rolandi, Giovanni Davì.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19353242     DOI： 10.1007/s11239-009-0332-4

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  14 in total

1.  The association of a mild FXII deficiency with myocardial infarction and venous thrombosis is completely unjustified.

Authors:  Antonio Girolami; Pamela Scarparo; Silvia Vettore
Journal:  J Thromb Thrombolysis       Date:  2009-03-13       Impact factor: 2.300

Review 2.  Pregnancies and oral contraceptive therapy in severe (homozygons) FXII deficiency: a study in 12 patients and review of the literature.

Authors:  A Girolami; N Zocca; B Girolami; A M Lombardi; F Fabris
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

Authors:  Carine J M Doggen; Frits R Rosendaal; Joost C M Meijers
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

4.  Reevaluation of the incidence of thromboembolic complications in congenital factor XII deficiency--a study on 73 subjects from 14 Swiss families.

Authors:  S Zeerleder; M Schloesser; M Redondo; W A Wuillemin; W Engel; M Furlan; B Lämmle
Journal:  Thromb Haemost       Date:  1999-10       Impact factor: 5.249

5.  In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.

Authors:  T Bombeli; M Jutzi; E De Conno; B Seifert; J Fehr
Journal:  Blood Coagul Fibrinolysis       Date:  2002-10       Impact factor: 1.276

6.  Evidence of a U-shaped association between factor XII activity and overall survival.

Authors:  G Endler; C Marsik; B Jilma; T Schickbauer; P Quehenberger; C Mannhalter
Journal:  J Thromb Haemost       Date:  2007-06       Impact factor: 5.824

7.  The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  James D Douketis; Peter B Berger; Andrew S Dunn; Amir K Jaffer; Alex C Spyropoulos; Richard C Becker; Jack Ansell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

8.  Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery.

Authors:  W M Halbmayer; A Haushofer; J Radek; R Schön; M Deutsch; M Fischer
Journal:  Coron Artery Dis       Date:  1994-05       Impact factor: 1.439

Review 9.  The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature.

Authors:  A Girolami; M L Randi; S Gavasso; A M Lombardi; F Spiezia
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

10.  Deep venous thrombosis and previous myocardial infarction in mild factor XII deficiency: a risk factor for both venous and arterial thrombosis.

Authors:  Gianfranco Lessiani; Angela Falco; Elvira Nicolucci; Giancarlo Rolandi; Giovanni Davì
Journal:  J Thromb Thrombolysis       Date:  2008-04-06       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.